| Dollars in millions, except as noted |
|
2003
|
2002
|
| Net Sales (dollars in billions) |
32.6 |
27.6
|
| Net Income (Loss) Available for Holders of Common Stock |
1,730 |
(338)
|
| Earnings (Loss) per Share – Diluted (in dollars) |
1.87 |
(0.37) |
| Research and Development Expenses |
981 |
1,066 |
| Capital Expenditures |
1,100 |
1,623 |
| Return on Stockholders' Equity |
18.9% |
(4.4)% |
| Dividends Declared per Share (in dollars) |
1.34 |
1.34 |